SIREN : 709804538
NOVARTIS GROUPE FRANCE is a French company founded 126 years ago, specialized in the sector Activités des sièges sociaux. Based in RUEIL-MALMAISON (92500), this company of category GE shows in 2024 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 916 298 € | 1 736 835 € | 957 355 € | 1 788 598 € | 2 229 619 € | 1 874 972 € | 32 040 € | 1 254 973 € | 1 522 919 € |
| Net income | 123 789 326 € | -28 645 000 € | -24 393 591 € | -29 497 641 € | 64 331 231 € | -26 216 005 € | 12 539 631 € | 94 351 906 € | -4 350 703 € |
| EBITDA | -13 231 € | 153 629 € | -1 008 455 € | 9 092 € | -212 548 € | -1 162 487 € | -20 387 891 € | 688 420 € | 984 454 € |
| Net margin | 6459.8% | -1649.3% | -2548.0% | -1649.2% | 2885.3% | -1398.2% | 39137.4% | 7518.2% | -285.7% |
In 2024, NOVARTIS GROUPE FRANCE achieves revenue of 1.9 M€. Revenue is growing positively over 9 years (CAGR: +2.9%). Vs 2023, growth of +10% (1.7 M€ -> 1.9 M€). After deducting consumption (0 €), gross margin stands at 1.9 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -13 k€, representing -0.7% of revenue. Warning negative scissor effect: despite revenue change (+10%), EBITDA varies by -109%, reducing margin by 9.5 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 123.8 M€, i.e. 6459.8% of revenue. This profit can be retained or distributed to shareholders.
1 916 298 €
1 916 298 €
-13 231 €
-188 011 €
123 789 326 €
-0.7%
The debt ratio (= Financial debt / Equity x 100) stands at 148%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 12.1 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 6440.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
148.381%
30.124%
6440.888%
12.112
81.2%
In 2024, the debt ratio of NOVARTIS GROUPE FRANCE (148.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of NOVARTIS GROUPE FRANCE (30.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of NOVARTIS GROUPE FRANCE (12.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 1.36. The company can meet its short-term commitments with a reasonable safety margin.
1.358
-496519.024
In 2024, the liquidity ratio of NOVARTIS GROUPE FRANCE (1.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of NOVARTIS GROUPE FRANCE (-496519.0x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 21 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 3442 days. Excellent situation: suppliers finance 3421 days of the operating cycle (retail model). WCR is negative (-153635 days): operations structurally generate cash. Notable WCR improvement over the period (-5626%), freeing up cash.
-817 805 831 €
21 j
3442 j
0 j
-153635 j
Based on 103 transactions of similar company sales in 2024, the value of NOVARTIS GROUPE FRANCE is estimated at 471 225 742 € (range 161 859 475€ - 1 268 571 063€). The price/revenue ratio is 0.38x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NOVARTIS GROUPE FRANCE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of NOVARTIS GROUPE FRANCE in 2024 is 1.9 M€.
Yes, NOVARTIS GROUPE FRANCE generated a net profit of 123.8 M€ in 2024.
The headquarters of NOVARTIS GROUPE FRANCE is located in RUEIL-MALMAISON (92500), in the department Hauts-de-Seine.
The tax return of NOVARTIS GROUPE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NOVARTIS GROUPE FRANCE operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.